Trial Profile
A Real-world, Retrospective, Cohort study to evaluate the effects of Proton pump inhibitor therapy on effectiveness of Ledipasvir/Sofosbuvir in patients with Hepatitis- C infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 Oct 2016 New trial record